Abstract:Background: Streptomyces chattanoogensis L10 is the industrial producer of natamycin and has been proved a highly efficient host for diverse natural products. It has an enormous potential to be developed as a versatile cell factory for production of heterologous secondary metabolites. Here we developed a genome-reduced industrial Streptomyces chassis by rational 'design-build-test' pipeline. Results: To identify candidate large non-essential genomic regions accurately and design large deletion rationally, we performed genome analyses of S. chattanoogensis L10 by multiple computational approaches, optimized Cre/loxP recombination system for high-efficient large deletion and constructed a series of universal suicide plasmids for rapid loxP or loxP mutant sites inserting into genome. Subsequently, two genome-streamlined mutants, designated S. chattanoogensis L320 and L321, were rationally constructed by depletion of 1.3 Mb and 0.7 Mb non-essential genomic regions, respectively. Furthermore, several biological performances like growth cycle, secondary metabolite profile, hyphae morphological engineering, intracellular energy (ATP) and reducing power (NADPH/NADP(+)) levels, transformation efficiency, genetic stability, productivity of heterologous proteins and secondary metabolite were systematically evaluated. Finally, our results revealed that L321 could serve as an efficient chassis for the production of polyketides. Conclusions: Here we developed the combined strategy of multiple computational approaches and site-specific recombination system to rationally construct genome-reduced Streptomyces hosts with high efficiency. Moreover, a genome-reduced industrial Streptomyces chassis S. chattanoogensis L321 was rationally constructed by the strategy, and the chassis exhibited several emergent and excellent performances for heterologous expression of secondary metabolite. The strategy could be widely applied in other Streptomyces to generate miscellaneous and versatile chassis with minimized genome. These chassis can not only serve as cell factories for high-efficient production of valuable polyketides, but also will provide great support for the upgrade of microbial pharmaceutical industry and drug discovery.

Rational engineering strategies for achieving high-yield, high-quality and high-stability of natural product production in actinomycetes

Generation of high rapamycin producing strain via rational metabolic pathway-based mutagenesis and further titer improvement with fed-batch bioprocess optimization.

Recent Advances in Synthetic Biology Approaches to Optimize Production of Bioactive Natural Products in Actinobacteria

Rational design for over-production of desirable microbial metabolites by precision engineering

Industrial antibiotic-producing actinobacteria: from strain improvement to bioprocess optimization and scale-up

Genome-based rational engineering of Actinoplanes deccanensis for improving fidaxomicin production and genetic stability

Metabolic Engineering of Streptomyces to Enhance the Synthesis of Valuable Natural Products

Industrial Production of Antibiotics in Fungi: Current State, Deciphering the Molecular Basis of Classical Strain Improvement and Increasing the Production of High-Yielding Strains by the Addition of Low-Molecular Weight Inducers

Rational Construction of Genome-Reduced and High-Efficient Industrial Streptomyces Chassis Based on Multiple Comparative Genomic Approaches.

Rational construction of a high-quality and high-efficiency biosynthetic system and fermentation optimization for A82846B based on combinatorial strategies in Amycolatopsis orientalis

Advanced Strategies for Production of Natural Products in Yeast

Advance of Tolerance Engineering on Microbes for Industrial Production

Synthetic biology approaches to actinomycete strain improvement

Rational development of mycobacteria cell factory for advancing the steroid biomanufacturing

Engineered biosynthesis of natural products in heterologous hosts.

Production of plant natural products through engineered <i>Yarrowia lipolytica</i>

Engineering Escherichia coli for l-Threonine Hyperproduction Based on Multidimensional Optimization Strategies

Improving the Microbial Production of Amino Acids: From Conventional Approaches to Recent Trends

Recent advances and prospects of <i>Bacillus amyloliquefaciens</i> as microbial cell factories: from rational design to industrial applications

Strategies for the Development of Industrial Fungal Producing Strains

Structure-driven protein engineering for production of valuable natural products